Cephalon, Inc. At our copmany, we never lose sight of why we’re in business: to improve health and enhance the quality of the lives of patients through smart application of science. Founded in 1987 as a biotech start-up, we have grown into one of the world’s top ten biopharmaceutical companies, with an impressive roster of first-in-class products, a deep and diverse pipeline, and total revenues of $2.81 billion in 2010. And even though we’ve grown to have thousands of employees in locations around the globe, we’ve never lost the agility and nimbleness of a start-up. Our portfolio of innovative treatments for central nervous system disorders, pain, and cancer include eight proprietary products in the United States, along with more than 100 products internationally. Our research pipeline is focused on developing new compounds and new indications for existing products, while our business collaborations capitalize on new products and smart drug delivery technologies. The single greatest measure of our success will always be the countless people who benefit from our medications every day. They are our true legacy and why we do what we do.